source
- New antibody-drug conjugates show promise as potential standard for extensive-stage small cell lung cancer at WCLC 2026The World Conference on Lung Cancer showcased several late‑stage trial updates, with a focus on new therapies for small cell lung cancer, the more aggressive form of the disease. Antibody‑drug con…
- FDA launches pilot to accelerate early-stage drug trials in the United StatesThe FDA announced a new pilot program called the Expedited Investigational New Drug Pilot as part of Operation Trialblazer. The initiative will pair up to ten qualified research institutions with…